School of Clinical Medicine, Jining Medical University, Jining, China.
Department of Paediatrics, Affiliated Hospital of Jining Medical University, Jining, China.
Medicine (Baltimore). 2024 Sep 27;103(39):e39774. doi: 10.1097/MD.0000000000039774.
This case report delves into the rare neurological condition known as alternating hemiplegia of childhood (AHC), focusing on its clinical manifestations, diagnostic approaches, and treatment options. AHC typically presents in infants under the age of 18 months with intermittent episodes of hemiplegia, often triggered by stressors such as environmental changes, bathing, or emotional stress. Recognizing the clinical features of AHC is crucial for early identification and intervention.
The paper presents a case of a 2-month-old child with nystagmus as the initial symptom, followed by limb movement disorder in the left upper limb and weakness in the right limbs. The child's condition did not improve with treatment at an external hospital, highlighting the complexity of the disease and the need for specialized care.
After a comprehensive review of the patient's medical history, physical examination, and imaging studies, the child was diagnosed with AHC. The diagnosis was confirmed through video electroencephalogram and whole-exome gene detection, which revealed a de novo mutation in the ATP1A3 gene, identified as pathogenic according to the American College of Medical Genetics and Genomics guidelines.
The child was admitted to Peking University First Hospital and treated with levetiracetam and flunarizine oral administration. These medications were chosen for their efficacy in managing the symptoms of AHC, particularly the hemiplegic episodes.
Post-treatment, the child experienced a reduction in the frequency and intensity of hemiplegic attacks compared to the initial stage. However, the child still exhibited paroxysmal symptoms and abnormal eye movements, and developmental milestones were delayed, indicating the need for ongoing care and monitoring.
This case underscores the importance of early recognition and prompt intervention in managing children with AHC. The varied clinical presentations of AHC necessitate vigilance for early differential diagnosis. Although AHC is currently incurable, appropriate treatment can mitigate the impact of complications and improve the long-term quality of life for affected children, facilitating better societal integration.
本病例报告深入探讨了一种罕见的儿童神经系统疾病,即交替性偏瘫(AHC),重点介绍了其临床表现、诊断方法和治疗选择。AHC 通常在 18 个月以下的婴儿中发病,间歇性出现偏瘫发作,通常由环境变化、洗澡或情绪压力等应激源触发。识别 AHC 的临床特征对于早期识别和干预至关重要。
本文报告了一例 2 个月大的婴儿,最初的症状为眼球震颤,随后出现左侧上肢运动障碍和右侧肢体无力。患儿在外院治疗后病情未见改善,突显了该疾病的复杂性和对专业治疗的需求。
在全面回顾患儿的病史、体格检查和影像学研究后,该患儿被诊断为 AHC。通过视频脑电图和全外显子基因检测进一步确诊,发现 ATP1A3 基因存在新生突变,根据美国医学遗传学与基因组学学会指南,该突变被认定为致病性突变。
患儿入住北京大学第一医院,接受左乙拉西坦和盐酸氟桂利嗪口服治疗。选择这些药物是因为它们在治疗 AHC 症状方面具有疗效,特别是在控制偏瘫发作方面。
治疗后,与初始阶段相比,患儿的偏瘫发作频率和强度均有所降低。然而,患儿仍存在阵发性症状和眼球运动异常,且发育里程碑延迟,表明需要持续的护理和监测。
本病例强调了早期识别和及时干预管理 AHC 患儿的重要性。AHC 的临床表现多样,需要警惕早期鉴别诊断。虽然目前 AHC 无法治愈,但适当的治疗可以减轻并发症的影响,改善患儿的长期生活质量,促进其更好地融入社会。